Malignant Tumors
Malignant tumors are abnormal growths of cells that can invade nearby tissues and spread to other parts of the body. They are commonly referred to as cancer and can affect various organs.
Psilocybin for Cancer-Related Depression
We are studying whether a single dose of psilocybin can help improve mood in adults aged 20-80 with major depression after a cancer diagnosis. Participants will compare its effects to a lower dose to assess changes in depressive symptoms.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Major Depressive Disorder
Major Depressive Disorder (MDD) is a serious mood disorder that affects how you feel, think, and handle daily activities, often leading to persistent sadness and loss of interest in life.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 20 and 80 years old?
- Do you have a diagnosis of cancer (any type) that is not currently being treated?
- Are you currently pregnant or breastfeeding?
- Are you taking any antidepressant medications like Prozac, Zoloft, or Lexapro?
- Have you had any major health issues like a stroke or heart problems?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Ucb-J
Pex010
Psilocybin
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Sahlgrenska University Hospital-Vastra Gotalandsregionen
Götebrogs Universitet
Göteborg, Sweden
Region Oerebro Laen
Örebro Universitet
Örebro, Sweden
Region Stockholm – SLSO
Karolinska Institutet
Solna, Sweden
Sponsor: Region Stockholm – SLSO
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.